SEC Filing Summary: AntriaBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AntriaBio, Inc. on February 19, 2013. The registrant is incorporated in Delaware with principal executive offices in Menlo Park, California. The filing serves to disclose a press release issued on the same date under Regulation FD (Fair Disclosure).
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural disclosure referencing an external press release (Exhibit 99.1) rather than a financial statement.
Material Changes
No material financial changes or comparative period data are detailed within the body of this Form 8-K. The report indicates that the information is "furnished" rather than "filed" for purposes of the Securities Exchange Act of 1934.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, or risk factors. It explicitly states that the information is not deemed an admission as to the materiality of any information required solely to satisfy Regulation FD requirements. The substantive content is located in the attached press release (Exhibit 99.1), which is not included in the provided text.
Key Facts for Investor Verification
- Verify the content of the press release dated February 19, 2013 (Exhibit 99.1), as the 8-K body contains no operational details.
- Confirm the company name is AntriaBio, Inc., noting the request metadata mentioned "Rezolute, Inc." which does not match the registrant in the filing text.
- Note that the information is furnished under Regulation FD and may not be considered "filed" for legal liability purposes under the Exchange Act.